Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,17%
1 106,36
-1,87
-0,17%
—1 108,231 109,651 115,881 105,59——
SIXC
Communications
SIXC
Communications
SIXC
+0,77%
610,29
+4,66
+0,77%
—605,63605,63611,69602,96——
SIXE
Energy
SIXE
Energy
SIXE
+0,10%
1 211,22
+1,27
+0,10%
—1 209,951 210,981 212,701 197,20——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,43%
1 750,71
-7,52
-0,43%
—1 758,231 759,031 760,641 739,69——
SIXM
Financials
SIXM
Financials
SIXM
-1,07%
628,17
-6,77
-1,07%
—634,94632,49632,49627,63——
SIXR
Staples
SIXR
Staples
SIXR
+0,26%
854,57
+2,20
+0,26%
—852,37850,81859,97849,13——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,90%
216,87
-1,98
-0,90%
—218,85218,85218,85215,61——
SIXT
Technology
SIXT
Technology
SIXT
+0,95%
3 561,94
+33,45
+0,95%
—3 528,493 565,203 578,773 509,18——
SIXU
Utilities
SIXU
Utilities
SIXU
-1,26%
903,31
-11,51
-1,26%
—914,82910,36910,36897,78——
SIXV
Health care
SIXV
Health care
SIXV
+0,63%
1 481,54
+9,27
+0,63%
—1 472,271 470,891 484,151 466,47——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,39%
2 399,95
+9,34
+0,39%
—2 390,612 387,312 409,702 373,97——
A1ZN34:BVMF
Astrazeneca Plc Bdr
151,94 R$
+1,09%
(+1,64) 1D
13 մյս, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for A1ZN34...
Open
157,81 R$
High
157,81 R$
Low
151,49 R$
Mkt. cap
295,14 մլրդ
Avg. vol.
416,00
Volume
9,00
52-wk high
190,40 R$
52-wk low
123,80 R$
Shares outstanding
1,55 մլրդ
No. of employees
96 հզր
News stories
From sources across the web
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, UK; Gothenburg, Sweden; and Gaithersburg, Maryland, US. AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About Astrazeneca Plc Bdr
CEOPascal Soriot
Employees96,1 հզր
Founded06 ապր, 1999 թ.
HeadquartersՔեմբրիջ, Cambridgeshire, Միացյալ Թագավորություն
Sector-
Websiteastrazeneca.com
Last report
29 ապր, 2026 թ.
Fiscal Period
Q1 2026
EPS / Est. (USD)
1,29 $ / 1,27 $
+1,43%beat
Revenue / Est. (USD)
15,29 մլրդ / 14,93 մլրդ
+2,39%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
14,46 մլրդ
15,19 մլրդ
15,50 մլրդ
15,29 մլրդ
Cost of goods sold
2,55 մլրդ
2,79 մլրդ
3,17 մլրդ
2,67 մլրդ
Cost of revenue
2,55 մլրդ
2,79 մլրդ
3,17 մլրդ
2,67 մլրդ
Research and development expenses
3,51 մլրդ
3,63 մլրդ
3,62 մլրդ
3,47 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,98 մլրդ
5,20 մլրդ
5,32 մլրդ
5,03 մլրդ
Operating expense
8,42 մլրդ
8,74 մլրդ
8,99 մլրդ
8,31 մլրդ
Total operating expenses
10,97 մլրդ
11,53 մլրդ
12,16 մլրդ
10,98 մլրդ
Operating income
3,49 մլրդ
3,66 մլրդ
3,35 մլրդ
4,31 մլրդ
Other non operating income
-
-
-247,00 մլն
-
EBT including unusual items
3,13 մլրդ
3,24 մլրդ
2,63 մլրդ
3,91 մլրդ
EBT excluding unusual items
3,11 մլրդ
3,32 մլրդ
3,05 մլրդ
3,97 մլրդ
Income tax expense
679,00 մլն
709,00 մլն
300,00 մլն
833,00 մլն
Effective tax rate
21,71%
21,86%
11,41%
21,28%
Other operating expenses
-72,00 մլն
-89,00 մլն
53,00 մլն
-189,00 մլն
Net income
2,45 մլրդ
2,53 մլրդ
2,33 մլրդ
3,08 մլրդ
Net profit margin
16,95%
16,67%
15,00%
20,15%
Earnings per share
2,17
2,38
2,12
1,29
Interest and investment income
65,00 մլն
85,00 մլն
135,00 մլն
73,00 մլն
Interest expense
-436,00 մլն
-434,00 մլն
-155,00 մլն
-393,00 մլն
Net interest expenses
-371,00 մլն
-349,00 մլն
-20,00 մլն
-320,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
4,88 մլրդ
5,21 մլրդ
4,11 մլրդ
5,67 մլրդ
Gain or loss from assets sale
-21,00 մլն
-31,00 մլն
-37,00 մլն
-34,00 մլն
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer